7 active trials 6 recruiting 6 Phase 3 10 disease areas
| Phase 1 | 1 | |
| Phase 2/3 | 3 | |
| Phase 3 | 3 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT07377643 | IBI354 With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in… | HER2-positive Breast Cancer | Recruiting | 2026-02-25 |
| NCT07265284 | A Study to Evaluate Efficacy and Safety of IBI112 in Adolescent Participants With… | Psoriasis | Recruiting | 2025-12-22 |
| NCT06945107 | A Study of Switching to Picankibart in Chinese Patients With Plaque Psoriasis With an… | Plaque Psoriasis | Active, Not Recruiting | 2026-03-25 |
| Phase 2/3 | ||||
| NCT07643623 | Neoadjuvant and Adjuvant Therapy Studies of Sintilimab Combined With Chemotherapy With or… | Resectable Gastric/Gastroesophageal Junction Adenocarcinoma | Recruiting | 2026-08-14 |
| NCT07490262 | A Study to Evaluate the Efficacy and Safety of IBI310 and Sintilimab Combination Therapy… | Hepatocellular Carcinoma (HCC) | Recruiting | 2026-04-16 |
| NCT07295509 | A Study of Picankibart in Patients With Active Psoriatic Arthritis | Psoriatic Arthritis | Recruiting | 2026-03-20 |
| Phase 1 | ||||
| NCT07589205 | Study of IBI3028 in Participants With Locally Advanced, Unresectable, or Metastatic Solid… | Solid Tumor | Recruiting | 2026-07-23 |
Psoriasis (2) · Breast Cancer (1) · Colorectal Cancer (1) · Head & Neck Cancer (1) · HER2-Positive Cancer (1) · Liver Cancer (1) · Lung Cancer (1) · Non-Small Cell Lung Cancer (NSCLC) (1) · Pancreatic Cancer (1) · Psoriatic Arthritis (1)